SG11201913157RA - Aav vector column purification methods - Google Patents

Aav vector column purification methods

Info

Publication number
SG11201913157RA
SG11201913157RA SG11201913157RA SG11201913157RA SG11201913157RA SG 11201913157R A SG11201913157R A SG 11201913157RA SG 11201913157R A SG11201913157R A SG 11201913157RA SG 11201913157R A SG11201913157R A SG 11201913157RA SG 11201913157R A SG11201913157R A SG 11201913157RA
Authority
SG
Singapore
Prior art keywords
purification methods
aav vector
column purification
vector column
aav
Prior art date
Application number
SG11201913157RA
Other languages
English (en)
Inventor
Younghoon Oh
Guang Qu
Original Assignee
Spark Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spark Therapeutics Inc filed Critical Spark Therapeutics Inc
Publication of SG11201913157RA publication Critical patent/SG11201913157RA/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361Ion-exchange
    • B01D15/362Cation-exchange
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34Size selective separation, e.g. size exclusion chromatography, gel filtration, permeation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361Ion-exchange
    • B01D15/363Anion-exchange
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201913157RA 2017-06-30 2018-06-29 Aav vector column purification methods SG11201913157RA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762527633P 2017-06-30 2017-06-30
US201762531744P 2017-07-12 2017-07-12
US201762567905P 2017-10-04 2017-10-04
PCT/US2018/040430 WO2019006390A1 (en) 2017-06-30 2018-06-29 AAV VECTOR COLUMN PURIFICATION METHOD

Publications (1)

Publication Number Publication Date
SG11201913157RA true SG11201913157RA (en) 2020-01-30

Family

ID=64742749

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201913157RA SG11201913157RA (en) 2017-06-30 2018-06-29 Aav vector column purification methods

Country Status (16)

Country Link
US (1) US20210079422A1 (ja)
EP (1) EP3658250A4 (ja)
JP (2) JP2020526190A (ja)
KR (2) KR102669561B1 (ja)
CN (1) CN111032176A (ja)
AU (1) AU2018291023B2 (ja)
BR (1) BR112019028299A2 (ja)
CA (1) CA3068622A1 (ja)
CL (1) CL2019003915A1 (ja)
CO (1) CO2020000911A2 (ja)
IL (1) IL271745A (ja)
MX (1) MX2020000216A (ja)
PE (1) PE20200737A1 (ja)
PH (1) PH12020500044A1 (ja)
SG (1) SG11201913157RA (ja)
WO (1) WO2019006390A1 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201508026D0 (en) 2015-05-11 2015-06-24 Ucl Business Plc Capsid
WO2020210600A1 (en) * 2019-04-11 2020-10-15 Regenxbio Inc. Methods of size exclusion chromatography for the characterization of recombinant adeno-associated virus compositions
EP3919613B1 (en) 2020-06-05 2024-08-07 Sartorius BIA Separations d.o.o. Enhanced purification of adeno-associated virus to more effectively remove contaminating dna
JP2023537565A (ja) * 2020-06-24 2023-09-04 バイオベラティブ セラピューティクス インコーポレイテッド タンパク質を発現するように改変されたレンチウイルスベクターの調製物から遊離第viii因子を除去する方法
US20220033782A1 (en) * 2020-07-29 2022-02-03 Pall Corporation Adenovirus-associated viruses separation method
EP4229205A1 (en) 2020-10-15 2023-08-23 F. Hoffmann-La Roche AG Nucleic acid constructs for va rna transcription
CN116348607A (zh) 2020-10-15 2023-06-27 豪夫迈·罗氏有限公司 用于同时基因活化的核酸构建体
JP2022182361A (ja) * 2021-05-28 2022-12-08 ダイセン・メンブレン・システムズ株式会社 微小有用物質の分離精製方法と分離精製装置
JP2022182360A (ja) * 2021-05-28 2022-12-08 ダイセン・メンブレン・システムズ株式会社 細胞外小胞の分離精製方法
MX2023014809A (es) * 2021-06-11 2024-01-29 Spark Therapeutics Inc Metodos de purificacion por columna de vectores aav.
AU2022358612A1 (en) * 2021-09-28 2024-04-11 Kashiv Biosciences, Llc An improved process of purification of fusion protein
CN114250222A (zh) * 2021-12-08 2022-03-29 苏州博腾生物制药有限公司 一种从动物组织中提取aav dna的方法
GB202117844D0 (en) * 2021-12-09 2022-01-26 Oxford Biomedica Ltd Purification method
JP2023141423A (ja) * 2022-03-24 2023-10-05 国立大学法人 東京大学 ウイルスの精製方法
WO2023198685A1 (en) 2022-04-13 2023-10-19 F. Hoffmann-La Roche Ag Method for determining aav genomes
WO2023227438A1 (en) 2022-05-23 2023-11-30 F. Hoffmann-La Roche Ag Raman-based method for the differentiation of aav particle serotype and aav particle loading status
WO2023232922A1 (en) 2022-06-03 2023-12-07 F. Hoffmann-La Roche Ag Method for producing recombinant aav particles
WO2024013239A1 (en) 2022-07-14 2024-01-18 F. Hoffmann-La Roche Ag Method for producing recombinant aav particles
WO2024024337A1 (ja) * 2022-07-28 2024-02-01 株式会社ダイセル 微小有用物質を含む液の精製濃縮装置及びそれを用いた微小有用物質を含む精製濃縮液の製造方法
WO2024056561A1 (en) 2022-09-12 2024-03-21 F. Hoffmann-La Roche Ag Method for separating full and empty aav particles
EP4385618A1 (en) 2022-12-16 2024-06-19 Chiral Technologies Europe SAS Composite material for bioseparations
WO2024165456A1 (en) 2023-02-07 2024-08-15 F. Hoffmann-La Roche Ag Method for the detection of anti-aav particle antibodies

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2325299A3 (en) * 1997-09-05 2011-10-05 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of recombinant AAV vectors
US6593123B1 (en) * 2000-08-07 2003-07-15 Avigen, Inc. Large-scale recombinant adeno-associated virus (rAAV) production and purification
ATE490307T1 (de) * 2003-05-21 2010-12-15 Genzyme Corp Verfahren zur herstellung von präparationen rekombinanter aav-virionen, die weitgehend frei von leeren capsiden sind
ES2693194T3 (es) * 2009-06-16 2018-12-10 Genzyme Corporation Métodos mejorados para la purificación de vectores de AAV recombinantes
BR112012018899A2 (pt) * 2010-01-28 2015-09-15 Philadelphia Children Hospital "método para purificar partículas de vetor de vírus adeno-associado."
PE20240371A1 (es) * 2015-12-01 2024-03-05 Spark Therapeutics Inc Metodos escalables para producir un vector viral adenoasociado (aav) recombinante en un sistema de cultivo celular en suspension sin suero adecuado para uso clinico
WO2017100676A1 (en) * 2015-12-11 2017-06-15 The Trustees Of The University Of Pennsylvania Scalable purification method for aav8
WO2017100674A1 (en) * 2015-12-11 2017-06-15 The Trustees Of The University Of Pennsylvania Scalable purification method for aav1
ES2918998T3 (es) * 2015-12-11 2022-07-21 Univ Pennsylvania Método de purificación escalable para AAVrh10
PE20190434A1 (es) * 2016-03-31 2019-03-21 Spark Therapeutics Inc PROCESO DE PRODUCCION DE rAAV A BASE DE COLUMNAS COMPLETAMENTE ESCALABLE

Also Published As

Publication number Publication date
RU2020103743A (ru) 2021-07-30
AU2018291023B2 (en) 2023-11-02
EP3658250A4 (en) 2021-10-27
KR20240093848A (ko) 2024-06-24
WO2019006390A1 (en) 2019-01-03
PH12020500044A1 (en) 2020-09-14
KR20200040749A (ko) 2020-04-20
CO2020000911A2 (es) 2020-06-19
JP2023029832A (ja) 2023-03-07
CA3068622A1 (en) 2019-01-03
CN111032176A (zh) 2020-04-17
EP3658250A1 (en) 2020-06-03
KR102669561B1 (ko) 2024-05-24
US20210079422A1 (en) 2021-03-18
JP2020526190A (ja) 2020-08-31
RU2020103743A3 (ja) 2021-09-30
AU2018291023A1 (en) 2020-02-06
BR112019028299A2 (pt) 2020-07-14
IL271745A (en) 2020-02-27
PE20200737A1 (es) 2020-07-23
CL2019003915A1 (es) 2020-06-19
MX2020000216A (es) 2020-09-03

Similar Documents

Publication Publication Date Title
IL271745A (en) AAV vector column purification methods
IL252072A0 (en) aav vectors target the central nervous system
IL255906A (en) water purification
IL261040B (en) Protein purification
GB2524625B (en) Purification column
GB201711481D0 (en) Protein purification
IL273933A (en) AAV vectors
GB2556682B (en) Steering system
IL273667A (en) Liquid purification system
SG11202005681SA (en) Purification system
GB201709637D0 (en) Water Purification
GB201600158D0 (en) Purification method
HUP1500502A2 (en) Process for the purification of cyclosporin-a
EP3574938A4 (en) CLEANING COLUMN
GB201710122D0 (en) Purification of DNA
GB201617240D0 (en) Purification process
GB201616968D0 (en) Steering system
GB201616966D0 (en) Steering system
GB201612305D0 (en) Alakati - manual surfing wheel
GB2544327B (en) Steering aid
GB201604934D0 (en) Purification of DNA
TWM533533U (en) Isopropanol purification system
GB201605002D0 (en) Spocket Wheel
GB201605055D0 (en) Single molecule controls
GB201600113D0 (en) Hydro-Gravity wheel